ClinicalTrials.gg
CompletedNCT01477112Updated Nov 22, 2011

Low Dose β-carotene Supplementation Diminishes Oxidative Stress in Type 2 Diabetics and Healthy Individuals

An interventional study of Betacarotene and Controls. No treatment in Diabetes Mellitus, Oxidative Stress and Iron Metabolism Disorders, sponsored by Instituto Venezolano de Investigaciones Cientificas. Completed at 1 site in Venezuela. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-11-22.

Sponsored by Instituto Venezolano de Investigaciones Cientificas · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
117
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Since diabetes has multiple etiologies and oxidative stress one of the proposed mechanisms, the objective is to determine the effect of supplementation with β-carotene to type 2 diabetics and healthy individuals, on iron metabolism, oxidative balance, and antioxidant plasma capacity, using doses similar to the daily nutritional requirement.

Read the detailed description

Type 2 diabetes is a chronic, multifactorial disease, and oxidative stress one of the pathophysiological mechanisms associated with its appearance and development. The objective was to determine the effect of supplementation with β-carotene to type 2 diabetics and healthy individuals, on iron metabolism, oxidative balance, and antioxidant plasma capacity, using doses similar to the daily nutritional requirement.

A total of 117 volunteers participated in the study. Type 2 diabetics (34) and healthy individuals (24), received 6 mg β-carotene for 45 d, and were compared to similar non-supplemented diabetic (33) and control (26) groups. Blood samples were taken at the beginning, end and 30 days after finishing supplementation, to determine hemoglobin, hematocrit unsaturated iron binding capacity, total iron binding capacity, transferrin saturation, ferritin, glycemia, glycosylated hemoglobin, cholesterol, triglycerides, HDL, LDL, oxidized LDL, copper, zinc, TBARS, FRAP, nitrites, GPx, SOD, folates, retinol and β-carotene.

02

Conditions studied

  • Diabetes Mellitus
  • Oxidative Stress
  • Iron Metabolism Disorders

Keywords

  • Type 2 diabetes
  • β-carotene
  • Oxidative balance
  • Oxidants
  • Antioxidants
03

In context

Diabetes Mellitus

8,290 studies on the registry are indexed under Diabetes Mellitus; 1,077 are open to participants now.

This study's enrollment of 117 is above the median of 80 across 6,023 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Instituto Venezolano de Investigaciones Cientificas is the lead sponsor of 5 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Patients with a diagnose of Type 2 diabetes mellitus of at least 5 years of diagnosis, in treatment with oral hypoglycemics Patients in regular control (once a month) in the Hospital

Exclusion criteria

Exclusion Criteria:

  • Hospitalized patient
  • Diabetic patient with diabetes related acute complications (ketoacidosis, hyperosmolar coma)in the 3 months previous to the study.
  • Individuals with infections that required antibiotics in the 3 weeks previous to the study.
  • Individuals with antibodies anti-insulin, diseases or in treatment with drugs.
  • Individuals with viral infections such as , hematological, renal or hepatic diseases.
  • Pregnancy
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

Hepatitis B tests

Hepatitis B is a virus that infects the liver. These are separate tests: HBsAg positive usually means a current infection (a recent vaccination can briefly cause it too); total anti-HBc (HBcAb) positive means an infection now or in the past; HBV DNA measures how much virus is in the blood.

Some studies accept a past infection if HBV DNA is undetectable, sometimes with antiviral medicine during the study. Check what this study allows.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
117 participants (actual)

Study arms

  • Experimental
    Supplemented Diabetics (DB)

    Diabetics supplemented with betacarotene for 45 days

    Dietary Supplement: Betacarotene

  • Experimental
    Unsupplemented Diabetics (DS)

    Diabetics without betacarotene supplementation

    Dietary Supplement: Controls. No treatment

  • Active comparator
    Supplemented Controls (CB)

    Controls supplemented with betacarotene for 45 days

    Dietary Supplement: Betacarotene

  • Active comparator
    Unsupplemented Controls (CS)

    Controls without betacarotene supplementation

    Dietary Supplement: Controls. No treatment

Interventions

  • Dietary supplementBetacarotene

    6 mg betacarotene in caplets for 45 days (daily)and reevaluate parameters 30 days after finishing supplementation

    Also known as: β-carotene as a soft gel capsule (GNC, Pennsylvania-USA)

  • Dietary supplementControls. No treatment

    Evaluate at time 0, 45 days and 75 days, but without receiving betacarotene supplements

    Also known as: No supplements

06

What researchers measure

Primary outcomes

  1. Changes in oxidative status

    Time frame: Time 0, 45 days and 75 days after supplementation

Secondary outcomes

  1. Hemoglobin and hematocrit

    Time frame: Time 0, 45 days and 75 days after supplementation

  2. Ferritin

    Enzyme linked immunosorbent assay (ELISA) with monoclonal antibodies

    Time frame: Time 0, 45 days and 75 days after supplementation

  3. Iron metabolism markers

    Serum iron, total iron binding capacity (TIBC) and unsaturated iron binding capacity (UIBC) were determined by the methods proposed by the International Committee of Standardization of Hematology.

    Time frame: Time 0, 45 days and 75 days after supplementation

  4. Blood Chemistry

    Glycemia, triglycerides, total cholesterol, LDL, and HDL were determined automatically in a Ciba Corning 550 Express autoanalizer, using classic enzymatic methods for the determination of these variables.

    Time frame: Time 0, 45 days and 75 days after supplementation

  5. Glycosylated Hemoglobin

    It was determined using a commercial kit (Bioscience, Caracas, Venezuela),

    Time frame: Time 0, 45 days and 75 days after supplementation

  6. Oxidized LDL

    Analyzed by a solid phase two-site enzyme immunoassay from Mercodia (Sweden), which contains 2 monoclonal antibodies directed against separated antigenic determinants on the oxidized apolipoprotein B molecule.

    Time frame: Time 0, 45 days and 75 days after supplementation

  7. Thiobarbituric Acid Reactive substances (TBARS)

    Were detected by the quantification of malondialdehyde present in the sample, by reacting 2 molecules of thiobarbituric acid with 1 molecule of malondialdehyde, which produces an abduct that is detected at 535 mn.

    Time frame: Time 0, 45 days and 75 days after supplementation

  8. Ferric Reducing ability of Plasma (FRAP).

    Measured after 4 and 10 min incubation, was used to determine the ability of plasma to reduce iron from ferric to ferrous state, based on the formation of a triazine-Fe+3 complex, that when reduced to Fe+2, generate a change in color that is measured at 593 nm.

    Time frame: Time 0, 45 days and 75 days after supplementation

  9. Activities of the enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPx).

    Determined by commercial kits (Cayman Chemicals, Pittsburg) following the recommended protocols

    Time frame: Time 0, 45 days and 75 days after supplementation

  10. Serum zinc and copper.

    By flame atomic absorption spectrophotometry

    Time frame: Time 0, 45 days and 75 days after supplementation

  11. β-carotene.

    It was determined by HPLC, with a reverse fase C18 column.

    Time frame: Time 0, 45 days and 75 days after supplementation

  12. Serum retinol

    It was determined by HPLC, with a reverse fase C18 column, as an indirect measure of betacarotene metabolism.

    Time frame: Time 0, 45 days and 75 days after supplementation

  13. Serum nitrites

    Were determined as an indirect measure of the concentration of nitric oxide, since nitrites are the stable end products of its degradation. Nitrates were reduced to nitrites by activated cadmium. Then sulfanilamide and nitrites generate a chromophore that reacts with naftilethylenediamine, to generate a product visible at 540 nm.

    Time frame: Time 0, 45 days and 75 days after supplementation

  14. Serum and erythrocyte folates.

    The method is based in the folate-dependent controlled growth of a Lactobacillus strain that is measured spectrophotometrically and quantified against a standard curve.

    Time frame: Time 0, 45 days and 75 days after supplementation

07

Study locations

1 site
  • Hospital Baudilio Lara
    Barquisimeto, Lara, Venezuela
08

References and documents

Publications

  • Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care. 1999 Dec;22(12):1978-83. doi: 10.2337/diacare.22.12.1978. PubMed 10587829 ↗
  • Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes. 2003 Sep;52(9):2346-52. doi: 10.2337/diabetes.52.9.2346. PubMed 12941775 ↗
  • Sugiura M, Nakamura M, Ikoma Y, Yano M, Ogawa K, Matsumoto H, Kato M, Ohshima M, Nagao A. The homeostasis model assessment-insulin resistance index is inversely associated with serum carotenoids in non-diabetic subjects. J Epidemiol. 2006 Mar;16(2):71-8. doi: 10.2188/jea.16.71. PubMed 16537987 ↗
  • Song Y, Cook NR, Albert CM, Van Denburgh M, Manson JE. Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial. Am J Clin Nutr. 2009 Aug;90(2):429-37. doi: 10.3945/ajcn.2009.27491. Epub 2009 Jun 2. PubMed 19491386 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 22, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01477112
Lead sponsor
Instituto Venezolano de Investigaciones Cientificas
Collaborators
Seguros Caracas Foundation, National Fund for Science and Technology, Science Mission
Responsible party
Maria Nieves Garcia-Casal (Director of Pathophysiology Laboratory, Instituto Venezolano de Investigaciones Cientificas) — Principal investigator
First posted
Nov 22, 2011
Start date
Jan 2010
Primary completion
Dec 2010
Completion
Dec 2010
Last update
Nov 22, 2011

Study contacts

Maria N Garcia-Casal, PhD
study director · Instituto Venezolano de Investigaciones Cientificas
Jose M Moreno, PhD
principal investigator · Instituto Venezolanode Investigaciones cientificas

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Beta Carotene

Start the discussion